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ABSTRACT
Background: A 67-year-old woman with a gastrointesti-
nal stromal tumor (GIST) of the stomach presented to our
outpatient clinic. Preoperative computed tomographic
scans and endoscopic examination revealed a spherical
submucosal tumor (7.7 x 6.1 x 6 cm) in the posterior wall
of the stomach less than 1cm away from the cardia, on the
small curvature side.
Methods: The tumor, which endosonographically had a
volume of 282 cm
3, was completely resected by a full-thick-
ness laparoscopic wedge excision without discontinuous
gastric resection. The whole procedure was performed using
4 working ports (one 12-mm and three 5-mm ports) and 1
camera port (12 mm). Because the resection margins were
tumor free on frozen sections and the distance between the
resection margin and cardia was wide enough not to com-
promise food passage, there was no need for total gastrec-
tomy or upper discontinuous gastric resection. The patient
was discharged on the fourth postoperative day after an
uneventful clinical course.
Results: Histological examination revealed a malignant
gastrointestinal stroma tumor of the stomach. The patient
was therefore enrolled for Imatinib adjuvant therapy.
Careful and long-term follow-up of 21 months showed no
signs of local or distant tumor recurrence. However, fur-
ther follow-up is needed to monitor for signs of possible
recurrence or distant metastases.
Conclusion: The described technique prevented proxi-
mal gastric resection and a risk of anastomosis without
compromising the food passage and radicality.
Key Words: Gastrointestinal stromal tumor, Laparoscopic
surgery, Stomach.
INTRODUCTION
Gastrointestinal stromal tumors (GIST) are pathologically
defined as tumors consisting of spindle-shaped cells of
mesenchymal origin, developing in the gastrointestinal
tract.1,2 Most of these tumors have been considered to be
of smooth muscle, and include leiomyoma, leiomyosar-
coma, and leiomyoblastoma.3
Surgical resection of the primary tumor is the treatment of
choice when cure is sought4 for patients with GISTs. Only
a decade has passed since the introduction of laparo-
scopic surgery for gastric tumors, and the concept of GIST
is of even shorter duration. Although it is too early to
reach any definitive conclusions, the evidence is growing
that the laparoscopic approach for gastric GIST is a valu-
able alternative for these patients. Although a conclusive
randomized-controlled trial with a proper number of
cases remains to be done, laparoscopic surgery for gastric
tumors is now an accepted modality for curative surgery.5
The goal of surgery for GIST is complete resection of
visible and microscopic disease, avoiding capsule rupture
and intraabdominal spillage of tumor cells. Because GIST
rarely metastasizes to local regional lymph nodes, lymph-
adenectomy is warranted only for evident nodal involve-
ment. These findings suggest that wedge resection with a
clear surgical margin is the most suitable procedure for the
surgical treatment of gastric GIST. In the case of large
subcardial tumors, especially located at the small curva-
ture, a discontinuous resection is often warranted.
In the following case report, we present a laparoscopic
technique that leaves the gastric passage intact.
CASE REPORT
A 67-year-old woman was admitted to the University Medical
Center Hamburg - Eppendorf with a history of epigastric
pain and anemia. The results of physical and laboratory
examinations were essentially normal, except for mild ane-
mia. Preoperative CT scan and endoscopic examination re-
vealed a spherical submucosal tumor with central depres-
sion in the posterior gastric wall less than 1cm away from the
cardia on the small curvature side (Figure 1). After routine
preoperative preparations the tumor, which endosono-
graphically had a volume of 282 cm
3 (6.1 x 7.7 x 6 cm), was
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CASE REPORTresected laparoscopically. Four working ports (one 12-mm
and three 5-mm ports) and 1 camera port (12 mm - perium-
bilical) were used. Intraoperative laparoscopy revealed no
lymph node swelling or serosal invasion of the tumor. The
location of the tumor was confirmed by intraoperative gas-
troscopy. The tumor was removed by creating a sleeve along
the small curvature, resecting both layers of the stomach
(whole thickness) using an Endo-GIA linear stapler and then
oversewing the staple line, without disturbing the gastroin-
testinal continuity (Figure 2). The left gastric artery was
included in the specimen, and the vagal innervation was
preserved. The hiatal dissection was necessary, but we did
not consider the fundoplication to diminish the risk of a
postoperative stricture formation. After completion of the
resection, additional intraoperative gastroscopy was per-
formed to exclude possible stenosis and stricture formation.
Total gastrectomy or upper discontinuous gastric resection
was not considered because the resection margins were
tumor free on frozen sections and a sufficient distance to
cardia was obtained, thus not hampering the food passage.
The postoperative course of the patient was uneventful. The
gastric tube was removed on the first, and feeding of the
patient started on the second postoperative day. Stool was
also obtained on the second postoperative day, and the
patient was discharged on the fourth postoperative day.
After the final pathology diagnosis was confirmed, we con-
sidered that a gastrectomy was not indicated. The patient is
currently well with no clinical sign of local or distant tumor
recurrence (endoscopy, CT, and postoperative series of up-
per gastrointestinal tract with Gastrographin swallow; Fig-
ure 3) 21 months after the initial operation. The patient does
not have any problems and tolerates a regular diet.
Pathology Findings
The locally resected tumor was 8.0 x 5.5 x 5.8 cm in size,
elastic, and hard in consistency, and its cut surface was
yellowish-white without hemorrhagic or necrotic foci.
Eight lymph nodes were dissected during the laparo-
scopic surgery, and none of them was positive on routine
histology. The resection margin was free of tumor, and the
distance to the tumor was 1.4 cm. Histologically, the
tumor was composed of elongated spindle-shaped cells,
with elongated nuclei with central necrosis. The Ki-67-
Labeling-Index was 10% to 20%. The mitotic activity of the
tumor cells was determined by counting the number of
apparent mitotic figures in 50 consecutive high-power
fields (HPF, 3400), in which only 10 mitoses on 50 HPF
were found. Formalin-fixed and paraffin-embedded spec-
imens were immunostained by a modified avidin-biotin
peroxidase complex method. Most of the tumor cells
showed immunoreactivity for CD34, but not for a ´-smooth
muscle actin (a ´SMA), desmin, or S-100 protein. The Kit
Mutation analysis of Exon 9, 11, and 13 revealed a muta-
tion in Exon 11. Because the necrosis, large tumor size,
Figure 1. Preoperative CT-scan detecting a large gatstric submu-
cosal gastrointestinal stromal tumors on a small curvature side.
Figure 2. Laparoscopic gastric tailoring for huge subcardial
gastrointestinal stromal tumors.
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mutation in Exon 11 was detected, the tumor was classi-
fied as a malignant GIST of the stomach. The patient was
therefore enrolled for Imatinib adjuvant therapy.
DISCUSSION
The cause, biology, and optimum management of GIST
remain largely unknown. The patients should be treated in
an organ-sparing and appropriately careful manner. Only a
decade has passed since the introduction of laparoscopic
surgery for gastric tumors, and the concept of GIST is of even
shorter duration. Although it is too early to reach any defin-
itive conclusions, the evidence is growing that the laparo-
scopic approach for gastric GIST is a valuable alternative for
these patients. Even the medical management of gastrointes-
tinal stromal tumors (GIST) has evolved rapidly. Recently
developed immunohistochemical staining methods allow
the differentiation of GIST from myogenic, neurogenic, and
other mesenchymal tumors.6 A tyrosine kinase receptor an-
tagonist (imatinib mesylate) has shown excellent results in
patients with unresectable or metastatic GIST,7 but surgical
resection of the primary tumor is the treatment of choice
when cure is sought.4
Although a conclusive randomized-controlled trial with a
proper number of cases remains to be done, laparoscopic
surgery for gastric cancer is now an accepted modality for
curative surgery.5,8 The goal of surgery for GIST is com-
plete resection of visible and microscopic disease, avoid-
ing capsule rupture and intraabdominal spillage of tumor
cells. As GIST rarely metastasizes to local regional lymph
nodes, lymphadenectomy is warranted only for evident
nodal involvement. These findings suggest that wedge
resection with a clear surgical margin is the most suitable
procedure for the surgical treatment of gastric GIST.
More recently, GISTs were classified into the 4 following
categories based on immunohistochemical and ultrastruc-
tural criteria1: tumors showing differentiation towards
smooth muscle cells, classified as leiomyomas or leiomy-
osarcomas2; tumors showing apparent differentiation to-
ward neural elements, classified as autonomic nerve tu-
mors or myenteric plexus tumors3; rare tumors showing
dural differentiation toward smooth muscle and neural
elements; and4 tumors lacking differentiation toward any
cell type.9 Some studies restricted the term “GIST” to refer
only to tumors belonging to the fourth category.
The National Comprehensive Cancer Network (NCCN)
task force report10 states that “laparoscopic or laparo-
scopic-assisted resection may be used for small (2 cm)
GISTs when the risk of intraoperative tumor rupture is
low. However, the use of laparoscopic resection is generally
discouraged for GIST.” Another report of the consensus
meeting for the management of gastrointestinal stromal tu-
mor under the sponsorship of the European Society of Med-
ical Oncology (ESMO)11 declares that “laparoscopic surgery
should be avoided, owing to the higher risk of tumor rupture
and subsequent peritoneal seeding. A laparoscopic resection
might be accepted in cases of small (2 cm) intramural
tumors.” According to these reports, laparoscopic surgery for
GIST is recommended only for cases of very small size
because of the risk of tumor cell seeding and subsequent
peritoneal recurrence. In Western countries, most GIST pa-
tients first present at an outpatient clinic with complaints of
vague abdominal discomfort or anemia due to a large bulky
GIST,12 and the size of the tumor is already too big to follow
the NCCN and ESMO guidelines. In Japan and some other
Asian countries, however, asymptomatic incidental GIST is
Figure 3. Postoperative series of upper gastrointestinal tract
(Gastrographin swallow) without a stricture 21 months after the
initial operation.
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ative perception of laparoscopic surgery for GIST may have
arisen partly as a result of these background differences.
Nowadays, gastric submucosal tumors are generally resected
by partial or total gastrectomy with lymphadenectomy. In
fact, a very few patients will die due to distant metastasis,
despite an initial diagnosis of a benign tumor. The recurrent
or metastatic form of the usual type of gastric cancer is lymph
node metastasis, whereas most malignant submucosal tu-
mors exhibit distant metastasis.15 This finding suggests that
lymphadenectomy is not necessary for malignant gastric sub-
mucosal tumors. Considering these tumor characteristics, lo-
cal resection might be the first choice of treatment.
Our work is only a small contribution to the treatment of
these patients. We were able to show that the dimensions
(smaller than 2 cm) are not the crucial criteria for the lapa-
roscopic approach in patients with gastric GIST, because the
largest diameter of tumor in this patient was 8cm (total
volume of 255 cm
3). Furthermore, we also showed that
although the minimal margin to the cardia was 1cm, there
was no need for classic (formal) gastric resection with vio-
lation of the GI tract continuity. The benefit for the patient
was therefore double. First, although the tumor was greater
than the maximal size anticipated for laparoscopic surgery
by the National Comprehensive Cancer Network (NCCN),
we were able to perform this resection in a laparoscopic
way. Secondly, the patient was spared total gastrectomy and
D-II lymphadenectomy as proposed by NCCN, especially for
proximal gastric tumors, and furthermore the continuity of
the gastric tract was preserved, so the feeding of the patient
started on the second postoperative day, and it was excel-
lently tolerated. Twenty-one months after the operation, the
patient was still free of local and distant tumor recurrence
and no stenosis or stricture was observed (Figure 3). Al-
though the patient was enrolled for Imatinib adjuvant ther-
apy, careful follow-up should be conducted considering the
possibility of distant metastasis.
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